US FDA

21 CFR 211.100(a) - Written Procedures - Establishment and Adherence

Plain-language explanation, inspection context and common violation patterns.

What it says

Written procedures must be established for production and process control designed to assure that drug products have the identity, strength, quality and purity they purport to have, and those procedures must be followed. Any deviation from a written procedure must be documented and justified.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

What FDA inspectors look for

Most common violation

A written procedure exists but is not followed in practice, with the gap discovered through batch record review or personnel interview rather than through the site's own deviation system. 21 CFR 211.100(a) has consistently ranked in the top four FDA drug 483 citation categories for multiple consecutive years.

Related regulations

Want a deeper, interactive breakdown?

GMPify's Regulation Explainer tool gives subscribers an AI-powered analysis of any 21 CFR, EU GMP, USP or ICH reference, with live inspection context.

Try the Regulation Explainer →